FORMA Therapeutics is a novel chemistry and integrated drug discovery platform for cancer therapies. Founded by Alexis Borisy, Nikolai Kley, and Steven Tregay in 2008, FORMA Therapeutics is backed by investors that include Cormorant Asset Management, EDBI, RA Capital Management, Samsara BioCapital, and Wellington Management and is headquartered in Cambridge.